Largos respondedores a la vía del VEGF en primera línea

10 / 46

2. Largos respondedores
con Sunitinib
*Molina et al. Long-term responders to sunitinib therapy for metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology, supl. 1 28.15
American Society of Clinical Oncology. 2010.
*Molina et al. Long-term responders to sunitinib therapy for metastatic renal cell carcinoma (mRCC). Clinical Genitourinary Cancer, Vol. 11, No. 3,